These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [The phenomenon of agglutination of lipid particles in hyperlipidemia by autoantibodies. Test of agglutination of activated lipid amulsions (AALE)]. Beaumont JL C R Acad Hebd Seances Acad Sci D; 1971 May; 272(18):2404-7. PubMed ID: 4997027 [No Abstract] [Full Text] [Related]
10. The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia. Joven J; Vilella E Clin Nephrol; 1997 Sep; 48(3):141-5. PubMed ID: 9342484 [TBL] [Abstract][Full Text] [Related]
12. Hyperlipidemia and renal disease: the use of animal models in understanding pathophysiology and approaches to treatment. Stevenson FT; Kaysen GA Wien Klin Wochenschr; 1999 Apr; 111(8):307-14. PubMed ID: 10378311 [TBL] [Abstract][Full Text] [Related]
14. [Apolipoproteins: their role in lipoprotein metabolism and the diagnostic value of their determination (literature review)]. Titov VN; Cherniad'eva IF; Alamdarova IN; Osipov SG Lab Delo; 1983; (6):29-38. PubMed ID: 6193318 [No Abstract] [Full Text] [Related]
15. [Blood lipid disorder according to modern laboratory and clinical concepts (hyperlipoproteinemia)]. Popescu PN; Idu SM Med Interna (Bucur); 1971 Mar; 23(3):293-302. PubMed ID: 5574926 [No Abstract] [Full Text] [Related]
16. Hyperlipidemia in four related male cheetahs (Acinonyx jubatus). Backues KA; Hoover JP; Bauer JE; Campbell GA; Barrie MT J Zoo Wildl Med; 1997 Dec; 28(4):476-80. PubMed ID: 9523643 [TBL] [Abstract][Full Text] [Related]
17. [Classification of the hyperlipoproteinemias]. Huth K Med Klin; 1970 Apr; 65(14):637-43. PubMed ID: 4927439 [No Abstract] [Full Text] [Related]
18. Serum lipoprotein pattern in the nephrotic syndrome. Markiewicz K Pol Med J; 1966; 5(4):737-43. PubMed ID: 5964892 [No Abstract] [Full Text] [Related]